BugSense Diagnostics Information

View Top Employees from BugSense Diagnostics

Urinary Tract Infections (UTIs) affect more than 152 million patients yearly and are, therefore, one of the most common types of diseases. Diagnostics of UTIs require time-consuming sample logistics and incubation by specialists in laboratories with high personnel costs (duration: 2-5 working days). As an initial treatment, patients are prescribed a broad-spectrum antibiotic until a more accurate infection assessment is available, leading to the development of multi-resistant germs. BugSense is a paper-based, patient-oriented solution combining cultivation and antibiotic resistance testing in one step, reducing testing time, costs, logistical effort, and especially unnecessary antibiotic prescriptions. The test should provide a user-friendly diagnostic and personalized treatment for anyone.

Website	https://www.bugsensedx.com/
Employees	10 (3 on RocketReach)
Industry	Biotechnology
Keywords	Urinary Tract Infection, Diagnostic Testing, Infection Diagnostics, Medical Diagnostics, Sample Testing, Laboratory Testing, Clinical Diagnostics, Disease Diagnostics, Pathogen Detection, Infectious Disease, Healthcare Diagnostics, Rapid Diagnostics, Diagnostic Tools, Bacteria Detection, Microbial Diagnostics, Point Of Care Testing, In Vitro Diagnostics, Test Kits, Medical Devices
Competitors	Roche, Abbott, Thermo Fisher Scientific, Siemens Healthineers, bioMérieux, Ortho Clinical Diagnostics - ANZ, Danaher Corporation, PerkinElmer, Inc., BD, Hologic, Inc. +44 more (view full list)